They didnt rely on the supplement alone
Obese subjects respond to the stimulatory effect of the ghrelin agonist growth hormone-releasing peptide-2 on food intake
Nooms SmartDose protocol titrates slowly to minimize nausea, diarrhea, and fatigue
Authors identified 51,408 adults with newly diagnosed type 2 diabetes and overweight or obesity who initiated treatment with either GLP-1 RAs (25,704 users) or SGLT2 inhibitors (25,704 users) following 1:1 propensity score matching to adjust for differences at baseline
Initial assessment typically includes 24-hour urinary free cortisol measurement, late-night salivary cortisol testing, or low-dose dexamethasone suppression testing to confirm hypercortisolism
A New Therapeutic Candidate for Cardiovascular Diseases: Berberine